Zhejiang Shapuaisi Pharmaceutical Co. Ltd.SSE: 603168

Announcement on Convening Performance Briefing for 2025 and Q1 2026

· Issued by Zhejiang Shapuaisi Pharmaceutical Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. has announced a performance briefing for the year and first quarter of the following year. The briefing is scheduled for a specific date and will be conducted online, allowing for investor interaction. The company aims to address common investor concerns during this session. Key executives will participate in the briefing to engage with investors and provide insights into the company's performance and strategy.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Convening Performance Briefing for 2025 and Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on 6ix

Earlier from Zhejiang Shapuaisi Pharmaceutical

Later from Zhejiang Shapuaisi Pharmaceutical

All Zhejiang Shapuaisi Pharmaceutical news releases